Track the 科伦药业 share price and the full directors' dealings record of the company, a listed equity based in China. Shares are quoted on CN CN, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 科伦药业 has published 7 reports. Market capitalisation: €46.9bn. The latest transaction was disclosed on 12 April 2022 (Purchase). Among the most active insiders: 刘思川. The full history is openly available.
7
Insider Decl.
0
Thresholds
·
7 ops.
Buy Volume
·
0 ops.
Sell Volume
25Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 13,100 of 25,821 companies
51.6
score / 100
Value
40
Quality
63
FCF yld1.5%
Earn yld2.5%
EV/EBITDA18.7x
ROE5.9%
Gross mgn48%
Net mgn9.2%
Debt/EBITDA0.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.